Correction of rat acute cholangitis using water-soluble C60 fullerene nanoparticles

TitleCorrection of rat acute cholangitis using water-soluble C60 fullerene nanoparticles
Publication TypeJournal Article
Year of Publication2018
AuthorsKuznietsova, HM, Dziubenko, NV, Rybalchenko, TV, Ogloblya, OV, Rybalchenko, VK
Abbreviated Key TitleDopov. Nac. akad. nauk Ukr.
DOI10.15407/dopovidi2018.02.102
Issue2
SectionBiology
Pagination102-108
Date Published2/2018
LanguageUkrainian
Abstract

The effects of water-soluble biocompatible C60 fullerenes (C60FAS) when applied intraperitoneally or per os on the liver function under rat α-naphthyl-isothiocyanate-induced cholangitis model are investigated. C60FAS when administered per os normalizes the direct bilirubin and ALT. Additionally, total bilirubin and ALP are normalized under C60FAS intraperitoneal injection, by indicating the attenuation of disease symptoms severity. Thus, the partial correction of cholangitis-induced liver failure caused by C60FAS is demonstrated, and the higher efficacy of C60FAS intraperitoneal injection is concluded.

KeywordsC60 fullerenes, cholangitis
References: 
  1. Skrypnyk, I. M., Melnyk, T. V. & Poiazhenko, M. M. (2007). Clinical hepatology. Poltava: Dyvosvit (in Ukrainian).
  2. Molodecky, N. A., Kareemi, H., Parab, R., Barkema, H. W., Quan, H., Myers, R. P. & Kaplan, G. G. (2011). Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology, 53, pp. 1590-1599. doi: https://doi.org/10.1002/hep.24247
  3. Zhu, G. Q., Shi, K. Q., Huang, G. Q., Wang, L. R., Lin, Y. Q., Braddock, M., Chen, Y. P., Zhou, M. T. & Zheng, M. H. (2015). A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget, 6, No. 29, pp. 26757-26769. doi: https://doi.org/10.18632/oncotarget.5610
  4. Angulo, P., Jorgensen, R. A., Kowdley, K. V. & Lindor, K. D. (2008). Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study. Dig. Dis. Sci., 53, No. 6, pp.1716-1720. doi: https://doi.org/10.1007/s10620-007-0052-6
  5. Prylutska, S. V., Grynyuk, I. I., Matyshevska, O. P., Prylutskyy, Yu. I., Ritter, U. & Scharff, P. (2008). Antioxidant properties of C60 fullerenes in vitro. Fullerenes, Nanotubes., Carbon Nanostruct, 16, No. 5-6, pp. 698-705. doi: https://doi.org/10.1080/15363830802317148
  6. Kuznietsova, H. M., Dziubenko, N. V., Chereschuk, I. O. & Rybalchenko, T. V. (2017). The impact of watersoluble C60 fullerenes on the development of acute colitis in rats. Studia biologica. 11, No. 1, pp. 41-50 (in Ukrainian).
  7. Halenova, T. I., Vareniuk, I. M., Roslova, N. M., Dzerzhynsky, M. E., Savchuk, O. M., Ostapchenko, L. I., Prylutskyy, Yu. I., Ritter, U. & Scharff, P. (2016). Hepatoprotective effect of orally applied water-soluble pristine C60 fullerene against CCl4-induced acute liver injury in rats. RSC Adv., 6, No. 102, pp. 100046-100055. doi: https://doi.org/10.1039/C6RA20291H
  8. Lynchak, O. V., Prylutskyy, Yu. I., Rybalchenko, V. K., Kyzyma, O. A., Soloviov, D., Kostjukov, V. V., Evstigneev, M. P., Ritter, U. & Scharff, P. (2017). Comparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo. Nanoscale Res. Lett., 12, No. 8, pp. 1-6. doi: https://doi.org/10.1186/s11671-016-1775-0
  9. Prylutska, S. V., Rotko, D. M., Prylutskyy, Yu. I. & Rybalchenko, V. K. (2012). Toxicity of carbon nanostructures in in vitro and in vivo systems. Modern Problems of Toxicology, No. 3-5, pp. 49-57 (in Ukrainian).
  10. Sumner, S. C. J., Snyder, R. W., Wingard, C., Mortensen, N. P., Holland, N. A., Shannahan, J. H., Dhungana, S., Pathmasiri, W., Han, L., Lewin, A. H. & Fennell, T. R. (2015). Distribution and biomarkers of carbon-14-labeled fullerene C60 ([14C(U)]C60) in female rats and mice for up to 30 days after intravenous exposure. J. Appl. Toxicol., 35, pp. 1452-1464. doi: https://doi.org/10.1002/jat.3110
  11. Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, S., Marschall, H. U., Karlsen, T. H., Melum, E., Kaser, A., Eksteen, B., Strazzabosco, M., Manns, M. & Trauner, M. (2014). Characterization of animal models for primary sclerosing cholangitis (PSC). J. Hepatol., 60, pp. 1290-1303. doi: https://doi.org/10.1016/j.jhep.2014.02.006
  12. Ritter, U., Prylutskyy, Yu. I., Evstigneev, M. P., Davidenko, N. A., Cherepanov, V. V., Senenko, A. I., Marchenko, O. A. & Naumovets, A. G. (2015). Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probed by various techniques. Fullerenes, Nanotubes, Carbon Nanostruct., 23, No. 6, pp. 530-534. doi: https://doi.org/10.1080/1536383X.2013.870900
  13. Sergijenko, V. I. & Bondareva, I. B. (2006). Mathematical statistics in slinical trials. Moscow: Geotar Me ditsina (in Russian).
  14. Kongo, M., Sasaki, E. & Harada, N. (1999). Change in hepatic antioxidant defense system with liver injury de velopment in rats with a single alpha-naphthylisothiocyanate intoxication. Toxicology, 139, No. 3, pp. 265-275. doi: https://doi.org/10.1016/S0300-483X(99)00131-6
  15. Takahashi, M., Kato, H., Doi, Y., Hagiwara A., Hirata-Koizumi, M., Ono, A., Kubota, R., Nishimura, T. & Hirose, A. (2012). Sub-acute oral toxicity study with fullerene C60 in rats. J. Toxicol. Sci., 37, No. 2, pp. 353-361. doi: https://doi.org/10.2131/jts.37.353